These two company have a promising drugs to treat Non hopkins lymphoma. They are about to emerge from bk. A good chance to get shares while it cheap. Many people are saying that it may be the next DNDN.
Biovest International, Inc., a biotechnology company, develops therapeutic anti-cancer vaccine for the treatment of low-grade Follicular Lymphoma in the United States. It develops BiovaxID, a Phase III clinical trial product, which is an injectable patient-specific vaccine to treat the follicular form of non-Hodgkin’s lymphoma.
Disclosure- i own shares in both.
Posted by aliceoner on :
(a pick by Roundup-thebulls, need to give credit to them for finding the play)